Indefinite Delivery Contract DAKF1199D0011

Analog Pharma, Inc. has been awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule to supply drugs, pharmaceuticals, and hematology-related products to the Veterans Integrated Service Network 12 (VISN 12), a civilian component of the Department of Veterans Affairs. The contract was awarded on September 29, 2025, with a ceiling value of $734,290.00 and a performance period extending through September 28, 2030. This award utilizes no...

All Phase Systems Integration, Inc. (UEI: L5WEEUUAAHW6) was awarded a Federal Supply Schedule contract under the General Services Administration's Multiple Award Schedule on March 25, 2025. This civilian agency contract, issued by the Federal Acquisition Service, carries a ceiling value of $500,000 and extends through March 24, 2030, providing a five-year period of performance. As a Multiple Award Schedule vehicle, this indefinite delivery contract enables federal agencies to place task orders...

The Department of the Navy Secretary of the Navy Office of Naval Research awarded a Basic Ordering Agreement (BOA) to Phase Sensitive Innovations Inc., a veteran-owned small business, in June 2022. This IDV contract has an ultimate completion date of June 3, 2027 and allows for streamlined procurement of the company's SBIR Phase III technologies related to Army Topic A18-040. Additionally, Phase Sensitive Innovations holds an Other Transaction Agreement awarded by the Department of the Army in...

Phathom Pharmaceuticals, Inc. (UEI: KPGYDW3H7ZW6) was awarded a multiple-award Federal Supply Schedule contract by the Veterans Integrated Service Network 12, a civilian component of the Department of Veterans Affairs, to supply drugs, pharmaceuticals, and hematology-related products under Federal Supply Classification code 65 I B. The contract, designated as a Federal Supply Schedule arrangement under the Pharmaceuticals and Drugs master schedule (FSS-61-IB), carries a ceiling value of $250,000...

This Indefinite Delivery Contract (IDC) was awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Pfenex Inc. The contract covers the advanced development of RPA563 and PX563L, with a single award and a total ceiling value of $144,092,373.11. The contract has an ultimate completion date of March 30, 2020, with an award date of August 14, 2015. No set-asides were used for this contract. The purpose of this contract is to support the...

The Environmental Protection Agency's Office of Land and Emergency Management awarded a single-award Indefinite Delivery Contract valued at $30.3 million to Consolidated Safety Services Incorporated, a Virginia-based environmental and scientific support services contractor, for the operation and maintenance of the Portable High-Throughput Integrated Laboratory Identification System (PHILIS). PHILIS provides mobile and fixed laboratory capabilities to detect chemical warfare agents, biological...

This is a multiple award Indefinite Delivery Contract (IDC) awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to provide comprehensive early phase clinical trial services. The $346.6 million contract, titled "Early Phase Clinical Trial Units (EPCTU)", facilitates Phase 0 through Phase II trials of investigational products against infectious diseases over a 10-year ordering period from...

Seqirus USA Inc. has been awarded a single-award Indefinite Delivery Contract valued at $30.9 million by the Department of Veterans Affairs National Acquisition Center for the supply of Influenza Virus Vaccine for the 2026-2027 flu season. The contract was awarded on March 15, 2026, with an ultimate completion date of March 14, 2027, and carries no set-aside designation. This procurement is a commercial item acquisition under Federal Acquisition Regulation Part 12 and will supply influenza...

Ionis Pharmaceuticals, Inc. was awarded a Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) program by Veterans Integrated Service Network 12 (VISN 12), a civilian component of the Department of Veterans Affairs, effective August 15, 2025, through August 14, 2030. The contract, valued at $225,000.00, represents a life cycle update transitioning one National Drug Code from temporary to permanent status within the Federal Supply Schedule framework. This...

This Blanket Purchase Agreement (BPA), awarded to Ionis Pharmaceuticals, Inc. on June 16, 2025, establishes a single-award indefinite delivery vehicle with a ceiling value of $4.26 million and an ultimate completion date of September 2, 2025. The agreement is funded through the National Acquisition Center, a civilian federal agency, and does not employ any set-asides. The BPA procures TryngolZA, a specialized pharmaceutical product, with this agreement replacing a prior BPA (36E79725A0020)....